Jian Xu

22.4k citations
215 papers · 17.3k indexed · 4 hit papers · h-index 49

Jian Xu

205 papers receiving 17.1k citations

Hit Papers

Molecular mechanisms of epithelial–mesenchym...6.3k20032026201020182.0k4.0k6.0k

Peers

Jian Xu
Comparison fields: 5 of 174
  • Cancer Research 3.5k
  • Oncology 4.1k
  • Molecular Biology 10.0k
  • Immunology 2.0k
  • Cell Biology 1.4k
Replace Bruce J. Aronow with:
Bruce J. Aronow United States
Hiroshi Inoue Japan
Jian Wang China
Douglas W. Losordo United States
Daniel Metzger France
Tong‐Chuan He United States
Makoto Noda Japan
Ryuichi Morishita Japan
Min Lü United States
Hiroyuki Shimada United States
Jian Xu relative to Bruce J. Aronow United States Bruce J. Aronow's profile →
Citations per field
00.5×1.5×
Bruce J. Aronow · 1×
Citations per year

Countries citing papers authored by Jian Xu

Since Specialization
Citations

This map shows the geographic impact of Jian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Xu more than expected).

Fields of papers citing papers by Jian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Xu. The network helps show where Jian Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jian Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jian Xu Line = papers co-authored together Jian Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20247
3 20244
4 20230
5 20236
6 202311
7 202211
8 202140
9 202111
10 20211
11 20218
12 201814
13 201810
14 201836
15 201814
16 201769
17
Upregulated serum miR-675 predicts poor prognosis for colorectal cancer.
20173
18 20114
19 201155
20 200791

About Jian Xu

Jian Xu is a scholar working on Cancer Research, Nuclear Energy and Engineering and Developmental Neuroscience, having authored 215 papers that have together received 17.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), Epigenetics and DNA Methylation (22 papers), MicroRNA in disease regulation (17 papers), Cancer-related gene regulation (15 papers), Neuroscience and Neuropharmacology Research (14 papers), Circular RNAs in diseases (14 papers), RNA modifications and cancer (13 papers) and Advanced Fluorescence Microscopy Techniques (10 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (4.1k citations) and Molecular Biology (10.0k citations). Jian Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Rik Derynck, Samy Lamouille, Jeffery D. Molkentin, Paul J. Lombroso, David A. LaVan, Pradeep Kurup, Thomas R. Kimball, Yan‐Shan Dai, Toru Oka and Jian Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026